A Combined Dexamethasone Desmopressin Test as an Early Marker of Postsurgical Recurrence in Cushing’s Disease | Zendy

Frédéric Castinetti | Zendy; Monique Martinie | Zendy; Isabelle Morange | Zendy; Henry Dufour | Zendy; Nathalie Stürm | Zendy; JeanGuy Passagia | Zendy; B. ConteDevolx | Zendy; Olivier Chabre | Zendy; Thierry Brue | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Combined Dexamethasone Desmopressin Test as an Early Marker of Postsurgical Recurrence in Cushing’s Disease

Author(s) -

Frédéric Castinetti,

Monique Martinie,

Isabelle Morange,

Henry Dufour,

Nathalie Stürm,

JeanGuy Passagia,

B. ConteDevolx,

Olivier Chabre,

Thierry Brue

Publication year - 2009

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2008-2234

Subject(s) - desmopressin , cushing's disease , medicine , dexamethasone , dexamethasone suppression test , disease , urology , endocrinology

Recurrence of Cushing's disease (CD) after transsphenoidal surgery (TSS) occurs in about 25% of cases. Twenty percent of patients with immediate postsurgical corticotroph deficiency will present late recurrence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore